These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 27529375

  • 1. Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies.
    Sajatovic M, Forester BP, Tsai J, Kroger H, Pikalov A, Cucchiaro J, Loebel A.
    J Clin Psychiatry; 2016 Oct; 77(10):e1324-e1331. PubMed ID: 27529375
    [Abstract] [Full Text] [Related]

  • 2. Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
    Rajagopalan K, Bacci ED, Ng-Mak D, Wyrwich K, Pikalov A, Loebel A.
    BMC Psychiatry; 2016 May 23; 16():157. PubMed ID: 27215976
    [Abstract] [Full Text] [Related]

  • 3. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A, Cucchiaro J, Silva R, Kroger H, Sarma K, Xu J, Calabrese JR.
    Am J Psychiatry; 2014 Feb 23; 171(2):169-77. PubMed ID: 24170221
    [Abstract] [Full Text] [Related]

  • 4. Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis.
    Chapel S, Chiu YY, Hsu J, Cucchiaro J, Loebel A.
    Clin Ther; 2016 Jan 01; 38(1):4-15. PubMed ID: 26730454
    [Abstract] [Full Text] [Related]

  • 5. Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study.
    Forester BP, Sajatovic M, Tsai J, Pikalov A, Cucchiaro J, Loebel A.
    Am J Geriatr Psychiatry; 2018 Feb 01; 26(2):150-159. PubMed ID: 29146409
    [Abstract] [Full Text] [Related]

  • 6. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T, Kroger H, Pikalov A, Loebel A.
    J Psychiatr Res; 2016 Jul 01; 78():86-93. PubMed ID: 27089521
    [Abstract] [Full Text] [Related]

  • 7. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L, Ketter TA, Cucchiaro J, Loebel A.
    J Affect Disord; 2014 Feb 01; 155():20-7. PubMed ID: 24246116
    [Abstract] [Full Text] [Related]

  • 8. Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.
    McIntyre RS, Cucchiaro J, Pikalov A, Kroger H, Loebel A.
    J Clin Psychiatry; 2015 Apr 01; 76(4):398-405. PubMed ID: 25844756
    [Abstract] [Full Text] [Related]

  • 9. LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY.
    Ketter TA, Sarma K, Silva R, Kroger H, Cucchiaro J, Loebel A.
    Depress Anxiety; 2016 May 01; 33(5):424-34. PubMed ID: 26918425
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis.
    Swann AC, Fava M, Tsai J, Mao Y, Pikalov A, Loebel A.
    CNS Spectr; 2017 Apr 01; 22(2):228-235. PubMed ID: 28300012
    [Abstract] [Full Text] [Related]

  • 12. Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder.
    Calabrese JR, Pikalov A, Streicher C, Cucchiaro J, Mao Y, Loebel A.
    Eur Neuropsychopharmacol; 2017 Sep 01; 27(9):865-876. PubMed ID: 28689688
    [Abstract] [Full Text] [Related]

  • 13. Effect of lurasidone on meaningful change in health-related quality of life in patients with bipolar depression.
    Calabrese J, Rajagopalan K, Ng-Mak D, Bacci ED, Wyrwich K, Pikalov A, Loebel A.
    Int Clin Psychopharmacol; 2016 May 01; 31(3):147-54. PubMed ID: 26717493
    [Abstract] [Full Text] [Related]

  • 14. Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension.
    Goldberg JF, Ng-Mak D, Siu C, Chuang CC, Rajagopalan K, Loebel A.
    CNS Spectr; 2017 Apr 01; 22(2):220-227. PubMed ID: 28264739
    [Abstract] [Full Text] [Related]

  • 15. Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A, Cucchiaro J, Silva R, Kroger H, Hsu J, Sarma K, Sachs G.
    Am J Psychiatry; 2014 Feb 01; 171(2):160-8. PubMed ID: 24170180
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA, LamLit Study Group.
    J Clin Psychiatry; 2009 Feb 01; 70(2):223-31. PubMed ID: 19200421
    [Abstract] [Full Text] [Related]

  • 17. Lurasidone: a review of its use in adult patients with bipolar I depression.
    Sanford M, Dhillon S.
    CNS Drugs; 2015 Mar 01; 29(3):253-63. PubMed ID: 25698146
    [Abstract] [Full Text] [Related]

  • 18. Effect of Lurasidone on Sexual Function in Major Depressive Disorder Patients With Subthreshold Hypomanic Symptoms (Mixed Features): Results From a Placebo-Controlled Trial.
    Clayton AH, Tsai J, Mao Y, Pikalov A, Loebel A.
    J Clin Psychiatry; 2018 Aug 07; 79(5):. PubMed ID: 30086213
    [Abstract] [Full Text] [Related]

  • 19. Recovery in bipolar depression: Post-hoc analysis of a placebo-controlled lurasidone trial followed by a long-term continuation study.
    Loebel A, Siu C, Rajagopalan K, Pikalov A, Cucchiaro J, Ketter TA.
    J Affect Disord; 2015 Nov 01; 186():376-82. PubMed ID: 26363720
    [Abstract] [Full Text] [Related]

  • 20. Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study.
    Tsai J, Thase ME, Mao Y, Ng-Mak D, Pikalov A, Loebel A.
    CNS Spectr; 2017 Apr 01; 22(2):236-245. PubMed ID: 28357969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.